Inactive
U

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

VIE Capital Project Performance Analyst

Business OperationsPosted on Oct 29
Full-timeBraine-l'Alleud, BelgiumNo salary listed

About the Job

Requirements

  • Hold a master's degree in engineering, project management, business engineering, industrial management, data analytics, or an equivalent discipline.
  • Ideally hold a project management certification or have initial experience in project management.
  • Be between 18 and 28 years old.
  • Hold the nationality of a member country of the European Economic Area.
  • Have not worked or lived in Belgium, where the mission will take place.
  • Be available to dedicate yourself to the mission full-time.
  • If French nationality or dual nationality, comply with France's national service obligations (Numéro Identifiant Défense).
  • Have a clean criminal record.
  • Be fluent in French and English, both written and spoken.

Responsibilities

  • Analyze performance data to identify improvement priorities and strengthen the effectiveness of capital investment projects.
  • Lead continuous improvement initiatives and contribute to transforming the engineering operating model.
  • Develop indicators and dashboards to monitor project performance, progress, and outcomes.
  • Support the deployment of standards, methods, and capabilities that enable consistent and efficient project delivery.
  • Collaborate with diverse teams and stakeholders to align priorities and support informed decision-making.
  • Contribute to communication and change management activities linked to the organisation’s strategic initiatives.

Desired Qualifications

  • Project management certification or initial experience in project management.

About the Company

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

UCB Pharma focuses on developing treatments for severe diseases in neurology and immunology. It discovers, develops, and commercializes novel molecules and generates products aimed at improving patient lives. The company works by researching and developing therapies, integrating patient insights to guide innovation, and investing over a quarter of revenue into scientific research. Its global presence (about 9,000 employees across 40 countries) and €5.3 billion 2023 revenue reflect its scale and commitment to bringing therapies to patients worldwide. UCB differentiates itself by combining direct patient engagement with substantial R&D investment to address unmet needs in neurology and immunology, aiming to transform lives through science and patient care.

Company size
10,001+
Company stage
IPO
Headquarters
City of Brussels, Belgium
Founded
1928

Recently Posted Jobs

Explore more opportunities at UCB Pharma

See more jobs